GlassScriptPhysician profile
Bridget D Hartman
NPI 1447541511
$1,169.63
in general payments reported to CMS, 2019-2025
18 companies · $98.86 in 2025
The $98.86 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $27.18 · 2021: $72.29 · 2022: $63.20 · 2023: $158 · 2024: $122 · 2025: $98.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $280.94 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $199.21 | 2023-2024 | Sotyktu |
| Lilly USA, LLC | $149.87 | 2019 | |
| Janssen Biotech, INC. | $68.44 | 2021-2025 | Tremfya, Stelara, Simponi |
| Sun Pharmaceutical Industries INC. | $68.20 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $66.08 | 2019 | |
| Dermira, INC. | $49.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.84 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.53 | 2019-2020 | |
| Helsinn Therapeutics (U.S.), INC. | $31.01 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $30.72 | 2019 | |
| Genzyme Corporation | $25.75 | 2024 | |
| Pfizer INC. | $24.82 | 2019 | |
| Genentech USA, INC. | $24.14 | 2019 | |
| Biofrontera INC. | $22.25 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.61 | 2025 | Otezla |
| Ucb, INC. | $13.50 | 2024 | Bimzelx |
| Galderma Laboratories, L.P. | $13.26 | 2024 | Oracea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Hartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.